Home › Cervical Cancer
Cervical Cancer clinical trials recruiting in the U.S.
114 studies for Cervical Cancer are recruiting participants at sites across the United States.
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
Cities with the most studies
- Houston, TX33 studies
- New York City, NY19 studies
- Nashville, TN19 studies
- Boston, MA18 studies
- Los Angeles, CA16 studies
- Arlington, VA16 studies
- San Antonio, TX14 studies
- St. Louis, MO13 studies
- Dallas, TX13 studies
- Chicago, IL12 studies
- Orlando, FL12 studies
- Baldwin Park, CA11 studies
- Columbus, OH11 studies
- Cleveland, OH10 studies
- San Diego, CA10 studies
- Philadelphia, PA10 studies
- Edison, NJ10 studies
- Queens, NY10 studies
- Atlanta, GA10 studies
- Portland, OR9 studies
- Miami, FL9 studies
- Durham, NC9 studies
- Minneapolis, MN9 studies
- Washington, DC9 studies
- Baltimore, MD8 studies
- Birmingham, AL8 studies
- Denver, CO7 studies
- Oklahoma City, OK7 studies
- Pittsburgh, PA7 studies
- Jacksonville, FL7 studies
- New Orleans, LA7 studies
- Seattle, WA7 studies
- Rochester, MN7 studies
- Salt Lake City, UT6 studies
- Grand Rapids, MI6 studies
- Austin, TX6 studies
- New Haven, CT6 studies
- Santa Monica, CA6 studies
- West Valley City, UT5 studies
- Detroit, MI5 studies
By state
- Alabama9 studies
- Arizona8 studies
- Arkansas3 studies
- California38 studies
- Colorado12 studies
- Connecticut9 studies
- District of Columbia5 studies
- Florida29 studies
- Georgia14 studies
- Illinois15 studies
- Indiana5 studies
- Iowa5 studies
- Kansas3 studies
- Kentucky7 studies
- Louisiana8 studies
- Maryland12 studies
- Massachusetts19 studies
- Michigan14 studies
- Minnesota18 studies
- Mississippi3 studies
- Missouri13 studies
- Nebraska4 studies
- Nevada5 studies
- New Jersey13 studies
- New Mexico4 studies
- New York23 studies
- North Carolina14 studies
- Ohio24 studies
- Oklahoma11 studies
- Oregon10 studies
- Pennsylvania15 studies
- Rhode Island4 studies
- South Carolina6 studies
- Tennessee21 studies
- Texas44 studies
- Utah10 studies
- Virginia20 studies
- Washington10 studies
- West Virginia3 studies
- Wisconsin7 studies
Recently updated studies
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05051722A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT07216703Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Sep 22, 2026 · NCT06814496A Study of Ivonescimab in People With Endometrial and Cervical Cancers
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 21, 2026 · NCT06925724Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT04038619PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT05758688Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05475171A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07109726Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
RecruitingObservational study
All ages · All sexes · Updated Sep 14, 2026 · NCT04723095GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04977453Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06535607Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 10, 2026 · NCT04865887A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06465069A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06400472A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06760819Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RecruitingObservational study
Ages 18 to 50 · Women · Updated Sep 2, 2026 · NCT06904365Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
Recruiting
Ages 21 and older · Women · Updated Aug 31, 2026 · NCT07662824Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 27, 2026 · NCT06492070From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.